View in EDS HTML Full Text

Conavi Medical Announces Clinical Use of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) Capabilities

Saved in:
Bibliographic Details
Title: Conavi Medical Announces Clinical Use of the Novasight Hybrid System with Simultaneous Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) Capabilities
Authors: Conavi Medical Inc.
Source: Business Wire (English). 08/13/2018.
Abstract: ConaviTM Medical Inc. (www.conavi.com) is pleased to announce the first clinical use of the NovasightTM Hybrid System, which enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT). IVUS or OCT are typically used by interventional cardiologists to image coronary anatomy during minimally invasive procedures, such as angiograms, angioplasty and stenting procedures. Drs. Tej Sheth and Natalia Pinilla Echeverri are co-investigators at Hamilton General Hospital where the procedures were performed under a Health Canada Investigational Testing Authorization. The technology originated from Dr. Courtney’s laboratory at Sunnybrook Research Institute in Toronto and is being commercialized by Conavi Medical. [ABSTRACT FROM PUBLISHER]
Database: Regional Business News
Full text is not displayed to guests.
Description
Abstract:ConaviTM Medical Inc. (www.conavi.com) is pleased to announce the first clinical use of the NovasightTM Hybrid System, which enables simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and Optical Coherence Tomography (OCT). IVUS or OCT are typically used by interventional cardiologists to image coronary anatomy during minimally invasive procedures, such as angiograms, angioplasty and stenting procedures. Drs. Tej Sheth and Natalia Pinilla Echeverri are co-investigators at Hamilton General Hospital where the procedures were performed under a Health Canada Investigational Testing Authorization. The technology originated from Dr. Courtney’s laboratory at Sunnybrook Research Institute in Toronto and is being commercialized by Conavi Medical. [ABSTRACT FROM PUBLISHER]